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children. Combined therapy of ICS + BD with or without LAs
was observed in 70% of privately insured children compared 
to 44% of social assistance children. Despite apparently better
management in the private group, OS use, indicating a severe
exacerbation, was 16% in the private compared to 12% in the
publicly insured group. While the average annual number of
claims were similar in the private and public groups (7.3 vs. 7.1),
privately insured children had more ICS claims (3.2 vs. 2.9) 
and fewer BD claims (2.9 vs. 3.9). CONCLUSIONS: Privately
insured children appeared to be better managed than social assis-
tance children. Differences in socioeconomic status and formu-
lary listings may explain observed differences. Policies governing
public and private drug plans must ensure adequate access to
necessary medications for children with asthma.
PAS4
PATTERNS OF PHARMACOTHERAPY UTILIZATION AMONG
CHILDREN AND ADOLESCENTS WITH MULTIPLE ASTHMA-
RELATED MORBID EVENTS ENROLLED IN A MEDICAID
PROGRAM
D’Souza AO, Smith M, Roy AN
West Virginia University, Morgantown, WV, USA
OBJECTIVE: To describe the asthma-related pharmacotherapy
utilization following a ﬁrst and second morbid event for asthma
among children and adolescents enrolled in Medicaid.
METHODS: Medicaid hospitalization and emergency room
(ER) claims with a primary ICD-9 CM diagnosis code for asthma
dated 2002 were extracted for recipients less than 21 years of
age. The corresponding asthma-related prescription claims also
were extracted. Recipients with at least two morbid events
(deﬁned as two consecutive ER or hospital visits at least 8 days
apart) formed the study cohort. Pharmacotherapy use for each
recipient was analyzed for up to a 30-day period following
his/her ﬁrst and second morbid event. RESULTS: A total of 214
recipients was identiﬁed as the study cohort consisting mainly 
of infants less than 6 years of age (50.0%), males (61.7%), 
and whites (82.2%). The proportion of recipients who ﬁlled a
prescription for a controller medication following the second
event was greater than the proportion following the ﬁrst event
(40.2% versus 34.1%). A greater proportion of recipients used
leukotriene modiﬁers (24.3%) and inhaled corticosteroids
(20.1%) than other controller drug classes following the ﬁrst
event, as well as following the second event (25.7% and 21.0%,
respectively). Following the ﬁrst event, 59.6% of recipients who
used a leukotriene modiﬁer continued using the same medication
after the second event, compared to only 27.9% of recipients
who used inhaled corticosteroids. With respect to demographic
groups, there was a very low proportion of recipients who were
black who used controller pharmacotherapy following the ﬁrst
(14.7%) and second event (23.5%). CONCLUSION: Although
there was an increase in the proportion of recipients who uti-
lized controller pharmacotherapy after a second morbid event,
there was a low use of these medications overall. Among demo-
graphic groups, blacks had the lowest utilization of controller
medications following morbid events.
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DRUG COST ANALYSIS OF TREATMENT FOR ASTHMA
OUTPATIENTS IN TAIWAN
Lu CH1,Tarn YH2
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OBJECTIVES: To investigate the trend of treatment costs 
for asthmatic outpatients in Taiwan from 1998 to 2002.
METHODS: Claimed database from Bureau of National Health
Insurance of Taiwan’s whole population were used to compute
the total treatment costs and drug related costs on asthmatic out-
patients during the year 1998 to 2002. Claims with ICD-9-CM
code of asthma were obtained and then sorted per person to cal-
culate the sum of treatment costs per person per year and the
ratio of drug costs per total treatment costs. RESULTS: The fol-
lowing present the yearly data from 1998 to 2002: 1) mean drug
costs per person per year: NT$.1286, 1486, 1873, 1940 and
2114; 2) mean of days per person per year: 26, 29, 36, 40 and
43 days; 3) total treatment costs of asthma : NT$. 4.3 billion,
2.9 billion, 2.4 billion, 2.5 billion and 2.7 billion; and 4) the
ratio of drug costs/total costs: 54.92%, 56.48%, 58.15%,
58.52% and 58.84%. CONCLUSIONS: Drug therapy for
patients with asthma play an important role in asthmatic care.
In Taiwan, the study indicated that drug costs per person per
year is growing every year. Future research will investigate the
appropriateness of these drug therapy and posible drug savings
in the future.
PAS6
IMPACT OF ASTHMA KNOWLEDGE ON HEALTH OUTCOMES
IN PEDIATRIC PATIENTS
Suksomboon N, Montakantikul P
Mahidol University, Payathai, Bangkok,Thailand
OBJECTIVE: To determine whether asthma knowledge of care-
givers could improve health outcomes in pediatric patients.
METHODS: The study design was a prospective randomized
controlled trial in asthma patients aged less than 12 years-old.
The study was carried out in asthma clinic at Queen Sirikit
National Institute of Child Health, Bangkok, Thailand between
August 2002 and March 2003. Eleven active and 11 control
patients were invited to attend a clinic. At the clinic the phar-
macists conducted interviews and asked all caregivers to answer
a questionnaire containing 18 true-false questions regarding
asthma knowledge. After completing the questionnaire, phar-
macists provided knowledge of asthma regarding treatment and
environmental care to caregivers in the intervention group.
During the study period, patients in both groups continued to
receive the usual care from their physicians. Patients and care-
givers were followed up during the next six months and the same
process was repeated. The outcome measure was the rate of hos-
pitalization in asthma patient between groups. RESULTS: At
baseline there are no signiﬁcant differences in asthma knowledge
between intervention and control group. At the end of study, the
intervention group is generally better at answering the asthma
questions correctly. The number of hospitalization in the inter-
vention group decreases from 31 to 13 (p < 0.05), whereas there
is no statistically signiﬁcant difference in the control group.
CONCLUSIONS: The present work suggests that pharmacist’s
involvement in asthma clinic has increased caregivers’ knowledge
leading to a decrease in the number of hospitalization. However,
further training is required for caregivers to optimize their role
in helping asthma patients. Further work could be carried out to
determine whether the results of this study are reﬂective of the
knowledge in adult patients.
PAS7
DIRECT AND INDIRECT COST OF ASTHMA IN AN EMPLOYER
POPULATION
Atherly A, Nurmagambetov T,Williams S
Centers for Disease Control and Prevention, Atlanta, GA, USA
OBJECTIVES: The purpose of this abstract is to examine the
direct and indirect costs associated with asthma in an employer
population. This work improves on previous studies of employer
populations with asthma by incorporating measures of the indi-
260 Abstracts
rect cost of asthma. METHODS: Data were drawn from the
2001 Medstat-Marketscan claims database. Medstat is a claims-
based database with over ﬁve-million members, representing an
employed population plus dependents. Individuals with asthma
were deﬁned as having at least two outpatient or one inpatient
event with a primary diagnosis of asthma (ICD-9 code 493).
Direct costs include expenditures for outpatient and inpatient
services and prescription drugs. Indirect costs include time lost
from work, short term disability and workers compensation.
RESULTS: The sample included 31,067 individuals with asthma
and 385,883 individuals without. Persons with asthma were sig-
niﬁcantly more likely to have paid absence from work (16.5%
vs. 5.2%), and when absences occur, they were 10.9% longer.
Similarly, persons with asthma are more likely to receive dis-
ability payments (8.6% vs. 2.0%), although the mean payments
are not statistically different. Persons with asthma are also more
likely to receive workers compensation payments (5.1% vs.
1.5%) which are signiﬁcantly more expensive ($7851 vs. $7073).
Overall mean expenditures for inpatient and outpatient care
were $311, the majority attributable to outpatient care ($207).
Inpatient stays were relatively infrequent, although expensive
when they occurred with a mean cost of $4736. CONCLUSION:
Asthma is a high cost chronic illness in employer populations.
Strategies to identify and manage high cost individuals may lead
to cost savings. However, asthma is an illness where total indi-
rect costs ($181) are an unusually higher percentage of the total
cost of illness, so much of the economic burden of the illness is
bourn directly by employers. This suggests that employer based
asthma programs may be appropriate.
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A DYAD APPROACH TO QUALITY OF LIFE MEASUREMENT IN
CHILDREN WITH ASTHMA
Mirabelli C, Cousins M, Boydell K, Ungar WJ
The Hospital for Sick Children,Toronto, ON, Canada
OBJECTIVES: The assessment of health-related quality of life
(HRQOL) is an essential component of evaluations of health
status, physical functioning, response to treatment and disease
progression. The measurement of HRQOL in children with
asthma often relies on parents as proxy respondents. Yet, several
studies have shown poor to moderate correlations between
parent and child responses, questioning the validity of the parent
proxy response. This pilot study tests a dyad approach, where
parent and child are interviewed together. It was hypothesized
that the dyad interview, by bringing parent and child perspec-
tives together, would create a more detailed and accurate picture
of HRQOL in children with asthma. METHODS: Children clin-
ically diagnosed with asthma aged 8 to 15 and their primary
caregivers were recruited from the Hospital for Sick Children
Asthma Clinic. Sixteen parent and child dyads consented and
were administered the Health Utilities Index Mark II & III (HUI
II/III), the Pediatric Asthma Quality of Life Questionnaire
(PAQLQ), and the Pediatric Quality of Life Inventory (PedsQL).
A qualitative approach was used wherein parents and children
were encouraged to discuss each question together. Interviews
were audiotaped and transcripts were analyzed thematically.
RESULTS: Consistent with Grounded Theory methodology,
observations were indexed according to a priori and a posteri-
ori categories and subcategories. Theoretical saturation was
achieved. The data showed that parents were a valuable resource
in overcoming problems associated with inaccurate recall,
respondent bias, frustration, psychic discomfort, anxiety and
comprehension. CONCLUSIONS: A dyad approach provided
children with access to their parent as an important information
resource, as an enabler and as an extension of the child’s cogni-
tive skills. Pilot data suggested that the dyad is more likely to
capture multi-factorial aspects of pediatric HRQOL than inde-
pendent assessments of parent or child.
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CHOOSING AMONG DIFFERENT TYPES OF MATCHING
TECHNIQUES
Baser O
Medstat, Inc, Ann Arbor, MI, USA
OBJECTIVE: The diversity of procedure in pharmaceutical
research requires a guideline to choose appropriate matching
method. Coherent guidelines for practice are absent. In this
paper we evaluate the several matching techniques and provide
a guideline to choose the best. METHODS: We proposed the fol-
lowing ways to check for the balance: 1) Two sample t-statistic
between the mean of the treatment group for each explanatory
variables with the mean of these variables in the control group;
2) The mean difference as a percentage of the average standard
deviations; 3) Percent reduction bias in means of explanatory
variables after matching and initially; 4) Compare treatment and
control density estimates for the explanatory variables; and 5)
Compare the density estimates of the propensity scores of control
units with that of the treated units. RESULTS: Medstat Market
Scan data used to provide empirical examples. We examined 2
to 1 matching, nearest neighborhood matching (NNM) with
replacement, NNM without replacement, MM matching (MM),
MM with calibers, stratiﬁcation method, kernel matching and
radius matching. Comparing techniques according to the above
criteria yield that 2 to 1 and NNM without replacement pro-
vides the worst balance. The difference between the control and
treatment variables was signiﬁcant. To choose among the rest,
we estimated the average treatment effect according to each
matching procedures and calculated the deviation from the mean
of estimated average treatment effect. MM with calibers where
calibers is selected as a quarter of standard deviation of estimated
propensity score provides least deviation, there this procedure
was superior to the others. CONCLUSION: Sensitivity analysis
of the matching techniques is especially important since none of
the proposed methods in literature is a priori superior to the
others. The joint consideration offers a way to assess the robust-
ness of the estimates.
CARDIOVASCULAR DISEASE—Angina/Ischemia
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COMPARISON OF ALTERNATIVE STRATEGIES FOR THE
DIAGNOSIS OF ACUTE CARDIAC ISCHEMIA IN EMERGENCY
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OBJECTIVES: This study compared diagnostic accuracy, time
spent in the emergency department/chest pain observation unit
(“ED/CPU”), medical costs, and litigation risk of alternative
diagnostic strategies for acute cardiac ischemia (ACI) in
ED/CPU. Rest single photon emission computed tomography
(SPECT) with an innovative cardiac imaging agent, BMIPP, was
compared to pre-admission standard of care in ED/CPU.
METHODS: A decision tree model was constructed for alterna-
tive diagnostic strategies based on comprehensive literature
review and expert panel input. Pre-admission standard of care 
is a complex scheme involving enzyme tests, ECG, X-ray, and
SPECT with other common cardiac imaging agents. Model para-
